0001415889-22-001057.txt : 20220203 0001415889-22-001057.hdr.sgml : 20220203 20220203190558 ACCESSION NUMBER: 0001415889-22-001057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220201 FILED AS OF DATE: 20220203 DATE AS OF CHANGE: 20220203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Moriarty John B CENTRAL INDEX KEY: 0001564621 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 22590281 MAIL ADDRESS: STREET 1: ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 512 2ND STREET, 4TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94107 4 1 form4-02032022_040246.xml X0306 4 2022-02-01 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001564621 Moriarty John B C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 false true false false EVP, CH. LEGAL OFFICER & SEC. Stock Option (Right to Buy) 7.02 2022-02-01 4 A 0 166250 0 A 2032-01-31 Common Stock 166250 166250 D 25% of the shares subject to the option vest on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. /s/ John B. Moriarty, Jr. 2022-02-03